Divi's Laboratories Limited (DIVISLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9741
First IPO Date
March 12, 2003
| Name | Title | Pay | Year Born |
| Kiran Satchandra Divi | Chief Executive Officer & Whole-Time Director | 307.7M | 1976 |
| Devendra Rao Sureddy | Whole-Time Director (Manufacturing) | 31.1M | 1962 |
| Nilima Prasad Divi | Whole-time Director, Chief Control Officer & Director of Commercial | 307M | 1983 |
| Venkata Ramana Nimmagadda | Executive Director | 451.8M | 1958 |
| Murali Krishna Prasad Divi | MD & Executive Director | 881.5M | 1951 |
| Venkatesa Perumallu Pasumarthy | Chief Financial Officer | 0 | 1961 |
| Y. T. S. Prasad | Global Quality Head | 0 | 1969 |
| Manoranjan Jasti | Chief Information Officer | 0 | N/A |
| Satish Choudhury | Company Secretary & Compliance Officer | 0 | N/A |
| Satya Prakash Divi | Vice President of Sales, Marketing & Logistics | 0 | 1977 |
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.